Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 345-350

  Shahabi, Shohreh ^b   Yang, Chia Ping Huang ^a,b   Goldberg, Gary L ^b   Horwitz, Susan Band ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Acetylated tubulin; EpCAM; Epothilone B; Hey cells; Taxol

Indexed keywords

ALPHA TUBULIN; CARBOPLATIN; CISPLATIN; DISCODERMOLIDE; EPITHELIAL CELL ADHESION MOLECULE; EPOTHILONE B; FLUOROURACIL; PACLITAXEL; TRICHOSTATIN A; TUBULIN; VINBLASTINE; ALKANE; CARBAMIC ACID DERIVATIVE; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; EPOTHILONE DERIVATIVE; HYDROXAMIC ACID; LACTONE; PYRONE DERIVATIVE; TUBULIN MODULATOR; TUMOR ANTIGEN;

ACETYLATION; ARTICLE; BREAST CANCER; CELL ADHESION; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSKELETON; DRUG ACTIVITY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE; METASTASIS; MICROTUBULE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE PROPERTY; BIOSYNTHESIS; DRUG EFFECTS; FEMALE; METABOLISM; OVARIAN NEOPLASMS; TUMOR CELL LINE;

ACETYLATION; ALKANES; ANTIGENS, NEOPLASM; CARBAMATES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; EPOTHILONES; FEMALE; HUMANS; HYDROXAMIC ACIDS; LACTONES; OVARIAN NEOPLASMS; PACLITAXEL; PYRONES; TUBULIN; TUBULIN MODULATORS; VINBLASTINE;

EID: 77957755342     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.07.005     Document Type: Article

References (39)

1. S. Shahabi, R. Smith, and G. Del Priore Fast facts: Gynecologic Oncology 2nd ed. 2010 Health Press 71 94
2. D.M. Bollag, P.A. McQueney, J. Zhu, O. Hensens, L. Koupal, and J. Liesch Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action Cancer Res 55 1995 2325 2333
3. R.J. Kowalski, P. Giannakakou, and E. Hamel Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)) J Biol Chem 272 1997 2534 2541
4. M. Harrison, and C. Swanton Epothilones and new analogues of the microtubule modulators in taxane-resistant disease Expert Opin Investig Drugs 17 2008 523 546
5. D. Donovan, and L.T. Vahdat Epothilones: clinical update and future directions Oncology (Williston Park) 22 2008 408 416 discussion 416, 421, 424 passim
6. M.N. Fornier Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues Clin Breast Cancer 7 2007 757 763
7. S. Goodin Ixabepilone: a novel microtubule-stabilizing agent for the treatment of metastatic breast cancer Am J Health Syst Pharm 65 2008 2017 2026
8. H.M. McDaid, S. Mani, H.J. Shen, F. Muggia, D. Sonnichsen, and S.B. Horwitz Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study Clin Cancer Res 8 2002 2035 2043
9. M. Balzar, F.A. Prins, H.A. Bakker, G.J. Fleuren, S.O. Warnaar, and S.V. Litvinov The structural analysis of adhesions mediated by Ep-CAM Exp Cell Res 246 1999 108 121
10. O. Gires, C.A. Klein, and P.A. Baeuerle On the abundance of EpCAM on cancer stem cells Nat Rev Cancer 9 2009 143 author reply 143.
11. L.M. Thurmond, J.B. Stimmel, A.C. Ingram, C.H. Ryan, D.M. Murray, and D.J. Eberwein Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism Cancer Immunol Immunother 52 2003 429 437
12. M. Balzar, I.H. Briaire-de Bruijn, H.A. Rees-Bakker, F.A. Prins, W. Helfrich, and L. de Leij Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions Mol Cell Biol 21 2001 2570 2580
13. P.A. Baeuerle, and O. Gires EpCAM (CD326) finding its role in cancer Br J Cancer 96 2007 417 423
14. M. Munz, P.A. Baeuerle, and O. Gires The emerging role of EpCAM in cancer and stem cell signaling Cancer Res 69 2009 5627 5629
15. D. Maetzel, S. Denzel, B. Mack, M. Canis, P. Went, and M. Benk Nuclear signalling by tumour-associated antigen EpCAM Nat Cell Biol 11 2009 162 171
16. V.A. Heinzelmann-Schwarz, M. Gardiner-Garden, S.M. Henshall, J. Scurry, R.A. Scolyer, and M.J. Davies Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer Clin Cancer Res 10 2004 4427 4436
17. J.H. Kim, D. Herlyn, K.K. Wong, D.C. Park, J.O. Schorge, and K.H. Lu Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer Clin Cancer Res 9 2003 4782 4791
18. M. Schmidt, D. Hasenclever, M. Schaeffer, D. Boehm, C. Cotarelo, and E. Steiner Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer Clin Cancer Res 14 2008 5849 5855
19. M.V. Blagosklonny, R. Robey, D.L. Sackett, L. Du, F. Traganos, and Z. Darzynkiewicz Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity Mol Cancer Ther 1 2002 937 941
20. Y. Zhang, N. Li, C. Caron, G. Matthias, D. Hess, and S. Khochbin HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo EMBO J 22 2003 1168 1179
21. A. Matsuyama, T. Shimazu, Y. Sumida, A. Saito, Y. Yoshimatsu, and D. Seigneurin-Berny In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation EMBO J 21 2002 6820 6831
22. L. He, C.P. Yang, and S.B. Horwitz Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines Mol Cancer Ther 1 2001 3 10
23. S. Xia, C.S. Kenesky, P.V. Rucker, A.B. Smith III, G.A. Orr, and S.B. Horwitz A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin Biochemistry 45 2006 11762 11775
24. C.P. Yang, and S.B. Horwitz Taxol mediates serine phosphorylation of the 66-kDa Shc isoform Cancer Res 60 2000 5171 5178
25. J.E. Lever Active amino acid transport in plasma membrane vesicles from Simian virus 40-transformed mouse fibroblasts. Characteristics of electrochemical Na+ gradient-stimulated uptake J Biol Chem 252 1977 1990 1997
26. M. Balzar, H.A. Bakker, I.H. Briaire-de-Bruijn, G.J. Fleuren, S.O. Warnaar, and S.V. Litvinov Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule Mol Cell Biol 18 1998 4833 4843
27. J.G. Chen, S. Liu-Chen, and G. Rudnick External cysteine residues in the serotonin transporter Biochemistry 36 1997 1479 1486
28. J.G. Chen, C.P. Yang, M. Cammer, and S.B. Horwitz Gene expression and mitotic exit induced by microtubule-stabilizing drugs Cancer Res 63 2003 7891 7899
29. C. Hubbert, A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito, and A. Nixon HDAC6 is a microtubule-associated deacetylase Nature 417 2002 455 458
30. C.P. Yang, L. Liu, A.E. Ikui, and S.B. Horwitz The interaction between mitotic checkpoint proteins, CENP-E and BubR1, is diminished in epothilone B-resistant A549 cells Cell Cycle 9 2010 1207 1213
31. M.A. Chaudry, K. Sales, P. Ruf, H. Lindhofer, and M.C. Winslet EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges Br J Cancer 96 2007 1013 1019
32. A. Burges, P. Wimberger, C. Kumper, V. Gorbounova, H. Sommer, and B. Schmalfeldt Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM × anti-CD3 antibody: a phase I/II study Clin Cancer Res 13 2007 3899 3905
33. M. Sonee, E. Barron, F.A. Yarber, and S.F. Hamm-Alvarez Taxol inhibits endosomal-lysosomal membrane trafficking at two distinct steps in CV-1 cells Am J Physiol 275 1998 C1630 C1639
34. S.F. Hamm-Alvarez, P.Y. Kim, and M.P. Sheetz Regulation of vesicle transport in CV-1 cells and extracts J Cell Sci 106 Pt 3 1993 955 966
35. R. Dhamodharan, M.A. Jordan, D. Thrower, L. Wilson, and P. Wadsworth Vinblastine suppresses dynamics of individual microtubules in living interphase cells Mol Biol Cell 6 1995 1215 1229
36. S.H. Zhuang, Y.E. Hung, L. Hung, R.W. Robey, D.L. Sackett, and W.M. Linehan Evidence for microtubule target engagement in tumors of patients receiving ixabepilone Clin Cancer Res 13 2007 7480 7486
37. M. Schmidt, M.E. Scheulen, C. Dittrich, P. Obrist, N. Marschner, and L. Dirix An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer Ann Oncol 21 2010 275 282
38. P. Ruf, and H. Lindhofer Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody Blood 98 2001 2526 2534
39. H. Zhong, B. Han, I.L. Tourkova, A. Lokshin, A. Rosenbloom, and M.R. Shurin Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth Clin Cancer Res 13 2007 5455 5462